Literature DB >> 10365900

Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis.

I E Petrakis1, N Vrachassotakis, V Sciacca, S I Vassilakis, G Chalkiadakis.   

Abstract

BACKGROUND: Erythromycin has recently been found to be a gastrointestinal prokinetic agent in humans. Acute hyperglycaemia has been associated with delayed gastric emptying in both healthy controls and diabetic patients. Our aim was to investigate in gastroparetic patients (diabetics and idiopathics) whether hyperglycaemia, per se, reduces gastric motility during erythromycin-induced acceleration of gastric emptying of solids.
METHODS: In 12 gastroparetic patients, 6 diabetics and 6 idiopathics, gastric emptying of solids was measured scintigraphically after giving placebo in normoglycaemia (5-8.9 mmol/l glucose) or 200 mg erythromycin lactobionate intravenously in normo- or hyperglycaemia (16-19 mmol/l glucose) induced by intravenous glucose infusion in random order on separate days.
RESULTS: Erythromycin in normoglycaemia accelerated solids gastric emptying compared with placebo in all patients by abolishing the lag-phase duration and by decreasing the retained percentage of a meal in the stomach at 120 and 150 min (14.5% +/- 5.3% versus 88.4% +/- 10.6% and 3.5% +/- 2.1% versus 70.1% +/- 15.4%, respectively) (P < 0.001). The retained isotopic percentage in the stomach after erythromycin in induced hyperglycaemia compared with erythromycin in normoglycaemia, at 120 and 150 min, was increased (51.9% +/- 9.8% versus 14.5% +/- 5.3%, and 24.5% +/- 5.9% versus 3.5% +/- 2.1%, respectively) (P < 0.001) but was decreased in comparison with placebo (P < 0.001). A significantly increased percentage of isotope was retained in the stomach of the diabetic patients at 120 and 150 min, compared with the idiopathics, only after giving erythromycin in the hyperglycaemic condition (57.6% +/- 8.7% versus 46.1% +/- 7.6% (P = 0.036) and 27.8% +/- 5.7% versus 21.1 +/- 4.4% (P = 0.040), respectively).
CONCLUSIONS: Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis and increases the retained isotopic meal in the stomach. Hyperglycaemia reduces gastric motility more in the diabetic patients with gastroparesis than in idiopathic patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365900     DOI: 10.1080/003655299750026416

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  17 in total

1.  Gastroparesis: current concepts and management.

Authors:  Tatsuhiro Masaoka; Jan Tack
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

Review 2.  Treatment options for patients with severe gastroparesis.

Authors:  Hasse Abrahamsson
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

3.  Noninvasive assessment of the effects of glucagon on the gastric slow wave.

Authors:  L Alan Bradshaw; Jared A Sims; William O Richards
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-20       Impact factor: 4.052

Review 4.  Gastroparesis: current diagnostic challenges and management considerations.

Authors:  Shamaila Waseem; Baharak Moshiree; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

5.  Delayed gastric emptying: whom to test, how to test, and what to do.

Authors:  Frank K Friedenberg; Henry P Parkman
Journal:  Curr Treat Options Gastroenterol       Date:  2006-07

6.  Relationship Between Gastric Emptying and Diurnal Glycemic Control in Type 1 Diabetes Mellitus: A Randomized Trial.

Authors:  Gopanandan Parthasarathy; Yogish C Kudva; Phillip A Low; Michael Camilleri; Ananda Basu; Adil E Bharucha
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

7.  Idiopathic and Diabetic Gastroparesis.

Authors:  Deirdre O'Donovan; Christine Feinle-Bisset; Karen Jones; Michael Horowitz
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

Review 8.  Diabetic gastroparesis: diagnosis and management.

Authors:  Jing Ma; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

Review 9.  Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment.

Authors:  Nicolas Intagliata; Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2007-08

10.  Glucose absorption and gastric emptying in critical illness.

Authors:  Marianne J Chapman; Robert J L Fraser; Geoffrey Matthews; Antonietta Russo; Max Bellon; Laura K Besanko; Karen L Jones; Ross Butler; Barry Chatterton; Michael Horowitz
Journal:  Crit Care       Date:  2009-08-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.